The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...

(Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-founder, will ...

Karthik and her team aimed to use CRISPR as a way to identify and isolate a protein generated by the bacteria that cause Lyme ...

A Philadelphia-area infant named Baby KJ made international headlines after doctors at Children’s Hospital of Philadelphia and Penn Medicine successfully treated his rare, life-threatening liver ...

A breakthrough in neural engineering is prompting wide debate over how far humans should push the boundaries between biological thought and digital computation. The unveiling of an ultra-thin implant ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...

The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...

Innovation cycles are shifting at a remarkable pace. Artificial intelligence, biotechnology and clean energy systems now influence how nations design public pol ...